Portal Biotechnologies is excited to be partnering with Bayer Co.Lab for a special cocktail reception with the ARPA-H Investor Catalyst Hub and Massachusetts General Brigham Gene and Cell Therapy Institute (GCTI) on Wednesday, May 22 from 5 - 7PM with doors opening at 4:30PM. Please join Portal Founder and CEO Armon Sharei, Chelsea Schiller, Director, ARPA-H Catalyst Hub, and Roger Hajjar, Director of GCTI, other members of the Cambridge cell and gene therapy innovation community and more!
Space is limited so make sure you register for your spot soon. Food and drinks will be provided. Please make sure to bring a government ID for entry into the building.
